Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.
People with long COVID have diverse clinical conditions that will require individualized and multidisciplinary approaches to treatment.
Questions remain about whether people with HIV are more at risk for severe COVID-19, as evidence to date is mixed.
Research suggests protective effect of natural infection or vaccination is likely to be persistent.
Study findings may help explain why wearing masks has been linked to lower disease severity in people with COVID-19.
People who have had COVID-19 appear to be protected against reinfection for at least a few months.
NIAID director Anthony Fauci, MD, and coauthors emphasize the need for a global response to COVID-19.
But new data add to the evidence that mother-to-infant transmission of the coronavirus appears to be rare.
More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.
Full-dose anticoagulation treatment for moderately ill COVID-19 patients reduced the need for ventilators.
The ACTIV-2 study aims to determine whether neutralizing antibodies reduce the duration of COVID-19 symptoms.
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.
Bamlanivimab did not speed clinical improvement or reduce the time to hospital discharge or sustained recovery.
Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.
Anthony Fauci, President-elect Joe Biden and senior legislators were vaccinated publicly to demonstrate their confidence in vaccine safety.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.